Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe Protocol-Reference-Cited by-同舟云学术

Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe Protocol

Published:2022-09-30 Issue:10 Volume:6 Page:e782
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Gupta Sanjeev Kumar,Singh Minu,Chandrashekar Pragna H.,Bakhshi Sameer,Trehan Amita,Gupta Ritu,Thakur Rozy,Gajendra Smeeta,Sharma Preity,Sreedharanunni Sreejesh,Sachdeva Manupdesh S.,Pushpam Deepam,Varma Neelam,Bansal Deepak,Jain Richa,Peyam Srinivasan,Moorman Anthony V.,Bhatia Prateek

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference40 articles.

1. A 50-year journey to cure childhood acute lymphoblastic leukemia.;Pui;Semin Hematol,2013

2. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period.;Magrath;Eur J Cancer,2005

3. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India.;Trehan;Pediatr Blood Cancer,2017

4. Acute lymphoblastic leukemia: a single center experience with Berlin, Frankfurt, and Munster-95 protocol.;Radhakrishnan;Indian J Med Paediatr Oncol,2015

5. Childhood cancer in India.;Ganguly;Cancer Epidemiol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IKZF1 in acute lymphoblastic leukemia: the rise before the fall?;Leukemia & Lymphoma;2024-08-29

2. IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia;Frontiers in Oncology;2024-04-03

3. Prognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy;Cancers;2023-11-15

4. Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India;Annals of Hematology;2023-07-21

5. Does granulocyte transfusion help pediatric cancer patients with sepsis?;Pediatric Blood & Cancer;2023-07-06